bioRxivPathology
Kidney osteoclast factors and matrix metalloproteinase expression in a mice model of diet-induced obesity and diabetes.
F. dos Santos-Macedo, B. Martins-Gregorio, E. Cardozo Paes de Almeida, L. de Souza Mendonca, R. de Souza Azevedo, C. Fernandes-Santos
Abstract
The role of RANKL/RANK/OPG system on bone remodeling is well known, and there is evidence that it is also important to cardiovascular and kidney pathology, although the underlying mechanisms are not elucidated so far. Thus, we investigated in a mice model of diet-induced obesity and diabetes if renal histopathological changes are associated with the expression of RANKL/RANK/OPG system and matrix metalloproteinases (MMPs). Three months old C57BL/6 mice were fed with control (AIN93M) or high-fat high sucrose (HFHS) diets for 21 weeks (CEUA/UFF #647/15). The HFHS group showed weight gain (+35%, P=0.0001), increased epididymal, inguinal and retroperitoneal fat pad weight (+121 %, P = 0.0006; +287 %, P = 0.0007 and; +286 %, P < 0.0001, respectively), and hyperglycemia (+43%, P=0.02). The kidney of some HFHS fed mice displayed mononuclear inflammatory cell infiltrate (40%), perivascular fibrosis (20%), and focal tubule mineralization (20%). Glomeruli hypertrophy was not detected. Unexpectedly, OPG, RANK, MMP-2 and MMP-9 expression was not altered in HFHS groups (Western blot analysis). In conclusion, the expression of RANKL/RANK/OPG system proteins and MMPs was not influenced by diet-induced obesity and diabetes in the kidney of male C57BL/6 mice, although some adverse histopathological remodeling is noticed in the renal tissue.
- organism: mouse
- assay: protein sequence
- research focus: cell type annotation
- research focus: differential expression
- research focus: cell signaling & trafficking
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A Novel Role of Hyaluronan and its Membrane Receptors, CD44 and RHAMM in Obesity-Related Glomerulopathy
Bingxue Qi, Vishal Musale, … Li Kang·BiomoleculesPeer-reviewed·Nov 14, 2025
- GLP-1 receptor agonist ameliorates obesity-induced chronic kidney injury via restoring renal lipid and energy metabolism homeostasis: revealed by metabolomics
- JAK-STAT pathway activation compromises nephrocyte function in a Drosophila high-fat diet model of chronic kidney disease
Yunpo Zhao, Jianli Duan, … Zhe Han·bioRxiv·Mar 7, 2024
- Six months of physical inactivity is insufficient to cause chronic kidney disease in C57BL/6J mice
Precious Chinonyerem Opurum, Stephen Thomas Decker, … Katsuhiko Funai·bioRxiv·Aug 29, 2024
- The non-steroidal mineralocorticoid receptor (MR) antagonist (FINERENONE) reverses Western diet-induced kidney disease by enhancing mitochondrial metabolism and decreasing lipid accumulation and inflammation
Komuraiah Myakala, Xiaoxin X. Wang, … Moshe Levi·American Journal of Physiology-Renal PhysiologyPeer-reviewed·Sep 29, 2025
- Rapamycin induced hyperglycemia is associated with exacerbated age-related osteoarthritis
D. M. Minton, C. J. Elliehausen, … A. R. Konopka·bioRxiv·May 21, 2021